| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/22/2004 | US20040013682 Drug design; competitive binding of glycoproteins; vaccines |
| 01/22/2004 | US20040013681 Stimulant of immunology response |
| 01/22/2004 | US20040013677 Mixtures; for therapy, prevention; purity polypeptide |
| 01/22/2004 | US20040013675 In situ detection of tumors; diagnosis of epilepsy, Alzheimer's disease, brain disorders |
| 01/22/2004 | US20040013674 Transdermal activator protein; antiproliferative agent; reducing solid tumors |
| 01/22/2004 | US20040013673 Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria |
| 01/22/2004 | US20040013671 Diagnosis, therapy of infections using labeled antibody |
| 01/22/2004 | US20040013670 Humanena/VASP-like protein splice variant |
| 01/22/2004 | US20040013668 Polypeptide antibody which binds to low density lipoprotein; quantitative analysis |
| 01/22/2004 | US20040013665 Immunoreactive peptides from Epstein-Barr virus |
| 01/22/2004 | US20040013664 Antiinflamamtory agents; antiallergens; antihistamines |
| 01/22/2004 | US20040013658 Method of inducing apoptosis by reducing the level of thiamin |
| 01/22/2004 | US20040013657 Novel nucleic acids and polypeptides |
| 01/22/2004 | US20040013655 Mutant Dna; transcription of genomes |
| 01/22/2004 | US20040013653 Stimulation of angiogenesis via enhanced endothelial expression of syndecan-4 core proteins |
| 01/22/2004 | US20040013650 Adjust concentration of circulating genes; in situ transformation of muscle by injecting virus vector |
| 01/22/2004 | US20040013647 Methods and compositions for treating a plaque-forming disease |
| 01/22/2004 | US20040013646 Modulator of TNF/NGF superfamily receptors and soluble oligomeric TNF/NGF superfamily receptors |
| 01/22/2004 | US20040013644 Interferon beta-like molecules |
| 01/22/2004 | US20040013640 Antitumor agents; rheumatic agents; antiarthritic agents; tissue factor protein binding to antibody |
| 01/22/2004 | DE10325172A1 Verfahren zur fermentativen Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterobacteriaceae A process for the fermentative preparation of L-amino acids using strains of the family Enterobacteriaceae |
| 01/22/2004 | DE10231115A1 Verfahren zur Herstellung von L-Aminosäuren unter Verwendung von Stämmen der Familie Enterbacteriaceae A process for the preparation of L-amino acids using strains of the Enterobacteriaceae family |
| 01/22/2004 | DE10217035A1 Rekrutierungsmodule von RhoA und RhoC Recruitment of RhoA and RhoC modules |
| 01/22/2004 | CA2800113A1 Reagents and methods for engaging unique clonotypic lymphocyte receptors |
| 01/22/2004 | CA2493675A1 Genes |
| 01/22/2004 | CA2493119A1 Peptides and methods of screening immunogenic peptide vaccines against alzheimer's disease |
| 01/22/2004 | CA2493061A1 Regulatory protein for nox enzymes |
| 01/22/2004 | CA2492859A1 Modulating developmental pathways in plants |
| 01/22/2004 | CA2492783A1 Method of transferring mutation into target nucleic acid |
| 01/22/2004 | CA2492716A1 Brachyspira hyodysenteriae vaccine |
| 01/22/2004 | CA2492691A1 Streptococcus pneumoniae pbp2x mini-protein and uses thereof |
| 01/22/2004 | CA2492654A1 Human immunosuppressive protein |
| 01/22/2004 | CA2492556A1 Hsp70 from arthrobacter |
| 01/22/2004 | CA2492554A1 Combination therapies with l-fmau for the treatment of hepatitis b virus infection |
| 01/22/2004 | CA2492313A1 Mutant proteins and use thereof for the manufacture of medicaments and the treatment of humans or animals suffering from conformational diseases |
| 01/22/2004 | CA2492303A1 Method for inducing a conformational transition in proteins such as pathogenic/infectious proteins |
| 01/22/2004 | CA2492275A1 Mutations of voltage-gated potassium channels |
| 01/22/2004 | CA2492200A1 Novel compositions and methods for the generation of mhc class ii compounds by peptide exchange |
| 01/22/2004 | CA2492169A1 Methods and materials relating to novel polypeptides and polynucleotides |
| 01/22/2004 | CA2492136A1 Nuclear fertility restorer genes and methods of use in plants |
| 01/22/2004 | CA2492099A1 Improved transporters and their uses |
| 01/22/2004 | CA2492068A1 Assays for assembly of ebola virus nucleocapsids |
| 01/22/2004 | CA2491971A1 Protein chips |
| 01/22/2004 | CA2491917A1 Altered insulin-like growth factor binding proteins |
| 01/22/2004 | CA2491805A1 Modified adenoviral fiber with ablated binding to cellular receptors |
| 01/22/2004 | CA2491737A1 Method for detection of bioactive peptides |
| 01/22/2004 | CA2491704A1 Immunogenic composition comprising a fusion protein and a saponin adjuvant |
| 01/22/2004 | CA2491320A1 Methods and compositions for modulating t helper (th) cell development and function |
| 01/22/2004 | CA2491279A1 Pituitary adenylate cyclase activating peptide (pacap) receptor (vpac2) agonists and their pharmacological methods of use |
| 01/22/2004 | CA2491234A1 Use of a gene for increasing the oil content in plants |
| 01/22/2004 | CA2490976A1 Poly-gamma-glutamate having ultra high molecular weight and method for using the same |
| 01/22/2004 | CA2490758A1 Dosage form of recombinant humanized monoclonal antibody 2c4 |
| 01/22/2004 | CA2490278A1 Components of the presenilin-complex |
| 01/22/2004 | CA2489410A1 Molecular antigen arrays |
| 01/22/2004 | CA2489189A1 Bicyclic oligopeptides and their use as glucagon receptor antagonists |
| 01/22/2004 | CA2489174A1 Rna-interference by single-stranded rna molecules |
| 01/22/2004 | CA2487378A1 Carboxy protection strategies for acidic c-terminal amino acids in chemical ligation of oligopeptides |
| 01/21/2004 | EP1382970A1 Novel mucin binding polypeptides |
| 01/21/2004 | EP1382686A1 Method for producing target substance by fermentation using a bacterial strain lacking the ArcA gene |
| 01/21/2004 | EP1382685A2 Process for the fermentative preparation of L-amino acids using strains of the enterobacteriaceae family with overexpressed rseB gene |
| 01/21/2004 | EP1382682A2 Modulating developmental pathways in plants |
| 01/21/2004 | EP1382679A2 Vascular Endothelial Growth Factor Related Protein (VRP) Antagonists |
| 01/21/2004 | EP1382678A1 Novel guanosine triphosphate-binding protein-coupled recepotr place 6002312 and its gene and production and use of the same |
| 01/21/2004 | EP1382616A2 Pharmaceutical composition for use in the treatment of abnormalities associated with the activity of a human Y5-receptor |
| 01/21/2004 | EP1382615A1 MCAM inhibitors |
| 01/21/2004 | EP1382614A1 Process for the purification of interleukin-4 and its muteins |
| 01/21/2004 | EP1382613A1 Novel G protein, polynucleotide encoding the same and utilization thereof |
| 01/21/2004 | EP1382612A1 Protein participating in restoration from cytoplasmic male sterility to fertility and gene encoding the same |
| 01/21/2004 | EP1382611A2 Bacillus strains and Pesticidal proteins |
| 01/21/2004 | EP1382348A2 Polynucleotide vaccine formula, particularly for treating bovine respiratory disease |
| 01/21/2004 | EP1382345A2 Uses of inhibitors of hemostasis |
| 01/21/2004 | EP1381971A2 Protein data analysis |
| 01/21/2004 | EP1381864A1 Detection of candida |
| 01/21/2004 | EP1381686A2 Inactivation of genes of the mep pathway |
| 01/21/2004 | EP1381685A2 Genes and proteins for the biosynthesis of polyketides |
| 01/21/2004 | EP1381683A2 Human fibroblast growth factor-related compositions |
| 01/21/2004 | EP1381681A1 The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 01/21/2004 | EP1381680A1 Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides |
| 01/21/2004 | EP1381678A2 Nucleic acid modification enzymes |
| 01/21/2004 | EP1381677A2 Neurotoxins with enhanced target specificity |
| 01/21/2004 | EP1381675A2 Method for replicating the hepatitis c virus |
| 01/21/2004 | EP1381629A2 RECEPTOR IN THE EDb FIBRONECTIN DOMAIN |
| 01/21/2004 | EP1381628A2 Inflammation-specific peptides and the uses thereof |
| 01/21/2004 | EP1381627A2 Polypeptides derived from amyloid precursor peptide (app) and their uses |
| 01/21/2004 | EP1381626A2 Human transporters and ion channels |
| 01/21/2004 | EP1381625A1 Mutants of green fluorescent protein |
| 01/21/2004 | EP1381624A2 Specific detection of proteolytic enzymes by means of a hybrid protein |
| 01/21/2004 | EP1381623A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
| 01/21/2004 | EP1381622A2 Human secreted proteins |
| 01/21/2004 | EP1381621A2 Novel nucleic acids and polypeptides |
| 01/21/2004 | EP1381392A1 Synthetic catalyst for selective cleavage of protein and method for selective cleavage of protein using the same |
| 01/21/2004 | EP1381388A1 Production of peptides in plants as n-terminal viral coat protein fusions |
| 01/21/2004 | EP1381303A2 Transmission assembly for a surgical biopsy device |
| 01/21/2004 | EP1381276A2 Method of treating or retarding the development of blindness |
| 01/21/2004 | EP1381272A2 Efficient methods for isolating functional g-protein coupled receptors and identifying active effectors and efficient methods to isolate proteins involved in olfaction and efficient methods to isolate and identifying active effectors |
| 01/21/2004 | EP1381268A2 Method for modifying plant biomass |
| 01/21/2004 | EP1010007B1 Collagen-peptide assay method |
| 01/21/2004 | EP0977596B1 Use of papovavirus capsid protein for delivery of therapeutic agents to neuronal cells |
| 01/21/2004 | EP0863982B1 Synthetic hpv11 virus-like particles |
| 01/21/2004 | EP0830376B1 Process for producing erythropoietin containing no animal proteins |